Log in to save to my catalogue
Log in to save to my catalogue

1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevima...

| Ask | Become a Library member

1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevima...

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_ofid_ofac492_1551

1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) for Preventing COVID-19 Hospitalizations in the Phase 3 TACKLE Trial

About this item

Full title

1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) for Preventing COVID-19 Hospitalizations in the Phase 3 TACKLE Trial

Author / Creator

Richard Hobbs, F D , Montgomery, Hugh , Padilla, Francisco , Kim, Kenneth , Simón Campos, Jesus Abraham , Arbetter, Douglas , Padilla, Kelly W , Reddy, Venkatesh P , Seegobin, Seth , Streicher, Katie , Viani, Rolando M , Koh, Gavin C KW and Esser, Mark T

Journal title

Open forum infectious diseases, 2022-12, Vol.9 (Supplement_2)

Language

English

Formats

Articles

More information

Alternative Titles

Full title

1924. Outpatient Treatment With the SARS-CoV-2–Neutralizing Antibody Combination AZD7442 (Tixagevimab/Cilgavimab) for Preventing COVID-19 Hospitalizations in the Phase 3 TACKLE Trial

Authors, Artists and Contributors

Author / Creator

Identifiers

Primary Identifiers

Record Identifier

TN_cdi_crossref_primary_10_1093_ofid_ofac492_1551

Permalink

https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_crossref_primary_10_1093_ofid_ofac492_1551

Other Identifiers

ISSN

2328-8957

E-ISSN

2328-8957

DOI

10.1093/ofid/ofac492.1551

How to access this item

Log in as a Library member

Full text available

View in old catalogue

Connecting people and collections